Matches in DBpedia 2016-04 for { <http://dbpedia.org/resource/GSK2831781> ?p ?o }
Showing triples 1 to 54 of
54
with 100 triples per page.
- GSK2831781 abstract "GSK2831781 is a monoclonal antibody being developed by GlaxoSmithKline (GSK) for autoimmune diseases. The antibody targets the T cell activation marker LAG-3, which is mainly expressed in inflamed tissues. In GSK's March 2015 Product development pipeline document the antibody is listed under 'Immuno-inflammation' candidates. GSK2831781 entered a Phase I clinical trial in psoriasis early in 2015.".
- GSK2831781 wikiPageID "46545835".
- GSK2831781 wikiPageLength "6481".
- GSK2831781 wikiPageOutDegree "41".
- GSK2831781 wikiPageRevisionID "705075803".
- GSK2831781 wikiPageWikiLink Afucosylated_monoclonal_antibodies.
- GSK2831781 wikiPageWikiLink Antibody-dependent_cell-mediated_cytotoxicity.
- GSK2831781 wikiPageWikiLink Autoimmune_disease.
- GSK2831781 wikiPageWikiLink BCG_vaccine.
- GSK2831781 wikiPageWikiLink Biotechnology.
- GSK2831781 wikiPageWikiLink Category:Monoclonal_antibodies.
- GSK2831781 wikiPageWikiLink Clinical_and_Experimental_Immunology.
- GSK2831781 wikiPageWikiLink Clinical_endpoint.
- GSK2831781 wikiPageWikiLink Complement_system.
- GSK2831781 wikiPageWikiLink Contract_research_organization.
- GSK2831781 wikiPageWikiLink Corticosteroid.
- GSK2831781 wikiPageWikiLink Cytotoxicity.
- GSK2831781 wikiPageWikiLink Fragment_crystallizable_region.
- GSK2831781 wikiPageWikiLink France.
- GSK2831781 wikiPageWikiLink French_Institute_of_Health_and_Medical_Research.
- GSK2831781 wikiPageWikiLink Frédéric_Triebel.
- GSK2831781 wikiPageWikiLink Fusion_protein.
- GSK2831781 wikiPageWikiLink GlaxoSmithKline.
- GSK2831781 wikiPageWikiLink Humanized_antibody.
- GSK2831781 wikiPageWikiLink Immunoglobulin_G.
- GSK2831781 wikiPageWikiLink LAG3.
- GSK2831781 wikiPageWikiLink Medical_literature.
- GSK2831781 wikiPageWikiLink Monoclonal_antibody.
- GSK2831781 wikiPageWikiLink Murinae.
- GSK2831781 wikiPageWikiLink Northwick_Park_Hospital.
- GSK2831781 wikiPageWikiLink PAREXEL.
- GSK2831781 wikiPageWikiLink Prima_BioMed.
- GSK2831781 wikiPageWikiLink Proof_of_concept.
- GSK2831781 wikiPageWikiLink Psoriasis.
- GSK2831781 wikiPageWikiLink T_cell.
- GSK2831781 wikiPageWikiLink T_helper_cell.
- GSK2831781 wikiPageWikiLink Transplant_rejection.
- GSK2831781 wikiPageWikiLink Transplantation_(journal).
- GSK2831781 wikiPageWikiLink Tuberculin.
- GSK2831781 wikiPageWikiLink Tumor_necrosis_factors.
- GSK2831781 wikiPageWikiLink Type_IV_hypersensitivity.
- GSK2831781 wikiPageWikiLink University_of_Nantes.
- GSK2831781 wikiPageWikiLinkText "GSK2831781".
- GSK2831781 wikiPageUsesTemplate Template:Reflist.
- GSK2831781 subject Category:Monoclonal_antibodies.
- GSK2831781 hypernym Antibody.
- GSK2831781 type Drug.
- GSK2831781 comment "GSK2831781 is a monoclonal antibody being developed by GlaxoSmithKline (GSK) for autoimmune diseases. The antibody targets the T cell activation marker LAG-3, which is mainly expressed in inflamed tissues. In GSK's March 2015 Product development pipeline document the antibody is listed under 'Immuno-inflammation' candidates. GSK2831781 entered a Phase I clinical trial in psoriasis early in 2015.".
- GSK2831781 label "GSK2831781".
- GSK2831781 sameAs Q19904145.
- GSK2831781 sameAs m.0134vzbm.
- GSK2831781 sameAs Q19904145.
- GSK2831781 wasDerivedFrom GSK2831781?oldid=705075803.
- GSK2831781 isPrimaryTopicOf GSK2831781.